|
1
|
Page NM, Butlin DJ, Lomthaisong K and
Lowry PJ: The human apolipoprotein L gene cluster: Identification,
classification, and sites of distribution. Genomics. 74:71–78.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Monajemi H, Fontijn RD, Pannekoek H and
Horrevoets AJ: The apolipoprotein L gene cluster has emerged
recently in evolution and is expressed in human vascular tissue.
Genomics. 79:539–546. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duchateau PN, Pullinger CR, Orellana RE,
Kunitake ST, Naya-Vigne J, O'Connor PM, Malloy MJ and Kane JP:
Apolipoprotein L, a new human high density lipoprotein
apolipoprotein expressed by the pancreas. Identification, cloning,
characterization, and plasma distribution of apolipoprotein L. J
Biol Chem. 272:25576–25582. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vanhollebeke B and Pays E: The function of
apolipoproteins L. Cell Mol Life Sci. 63:1937–1944. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomson R and Finkelstein A: Human
trypanolytic factor APOL1 forms pH-gated cation-selective channels
in planar lipid bilayers: Relevance to trypanosome lysis. Proc Natl
Acad Sci USA. 112:2894–2899. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhaorigetu S, Wan G, Kaini R, Jiang Z and
Hu CA: ApoL1, a BH3-only lipid-binding protein, induces autophagic
cell death. Autophagy. 4:1079–1082. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Büttner S, Ruli D, Vögtle FN, Galluzzi L,
Moitzi B, Eisenberg T, Kepp O, Habernig L, Carmona-Gutierrez D,
Rockenfeller P, et al: A yeast BH3-only protein mediates the
mitochondrial pathway of apoptosis. EMBO J. 30:2779–2792. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bechet J, Greenson M and Wiame JM:
Mutations affecting the repressibility of arginine biosynthetic
enzymes in Saccharomyces cerevisiae. Eur J Biochem.
12:31–39. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Springael JY, De Craene JO and André B:
The yeast Npi1/Rsp5 ubiquitin ligase lacking its N-terminal C2
domain is competent for ubiquitination but not for subsequent
endocytosis of the Gap1 permease. Biochem Biophys Res Commun.
257:561–566. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jacobs P, Jauniaux JC and Grenson M: A
cis-dominant regulatory mutation linked to the argB-argC gene
cluster in Saccharomyces cerevisiae. J Mol Biol.
139:691–704. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mumberg D, Müller R and Funk M:
Regulatable promoters of Saccharomyces cerevisiae: Comparison of
transcriptional activity and their use for heterologous expression.
Nucleic Acids Res. 22:5767–5768. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Westermann B and Neupert W:
Mitochondria-targeted green fluorescent proteins: Convenient tools
for the study of organelle biogenesis in Saccharomyces
cerevisiae. Yeast. 16:1421–1427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Volland C, Urban-Grimal D, Géraud G and
Haguenauer-Tsapis R: Endocytosis and degradation of the yeast
uracil permease under adverse conditions. J Biol Chem.
269:9833–9841. 1994.PubMed/NCBI
|
|
15
|
Boeckstaens M, Merhi A, Llinares E, Van
Vooren P, Springael JY, Wintjens R and Marini AM: Identification of
a novel regulatory mechanism of nutrient transport controlled by
TORC1-Npr1-Amu1/Par32. PLoS Genet. 11:e10053822015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gregg C, Kyryakov P and Titorenko VI:
Purification of mitochondria from yeast cells. J Vis Exp.
30:e14172009.
|
|
17
|
Piskur J, Rozpedowska E, Polakova S,
Merico A and Compagno C: How did Saccharomyces evolve to
become a good brewer? Trends Genet. 22:183–186. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Parrella E and Longo VD: The chronological
life span of Saccharomyces cerevisiae to study mitochondrial
dysfunction and disease. Methods. 46:256–262. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crowley LC, Christensen ME and Waterhouse
NJ: Measuring mitochondrial transmembrane potential by TMRE
staining. Cold Spring Harb Protoc 2016. 2016. View Article : Google Scholar
|
|
20
|
Hoffmann HP and Avers CJ: Mitochondrion of
yeast: Ultrastructural evidence for one giant, branched organelle
per cell. Science. 181:749–751. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pevala V, Kolarov J and Polčic P:
Alterations in mitochondrial morphology of Schizosaccharomyces
pombe induced by cell-death promoting agents. Folia Microbiol
(Praha). 52:381–390. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vanwalleghem G, Fontaine F, Lecordier L,
Tebabi P, Klewe K, Nolan DP, Yamaryo-Botté Y, Botté C, Kremer A,
Burkard GS, et al: Coupling of lysosomal and mitochondrial membrane
permeabilization in trypanolysis by APOL1. Nat Commun. 6:80782015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zamzami N, Marchetti P, Castedo M,
Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and
Kroemer G: Sequential reduction of mitochondrial transmembrane
potential and generation of reactive oxygen species in early
programmed cell death. J Exp Med. 182:367–377. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akl I, Lelubre C, Uzureau P, Piagnerelli
M, Biston P, Rousseau A, Badran B, Fayyad-Kazan H, Ezedine M,
Vincent JL, et al: Apolipoprotein L expression correlates with
neutrophil cell death in critically ill patients. Shock.
47:111–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Uzureau S, Coquerelle C, Vermeiren C,
Uzureau P, Van Acker A, Pilotte L, Monteyne D, Acolty V,
Vanhollebeke B, Van den Eynde B, et al: Apolipoproteins L control
cell death triggered by TLR3/TRIF signaling in dendritic cells. Eur
J Immunol. 46:1854–1866. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Francis BR, White KH and Thorsness PE:
Mutations in the Atp1p and Atp3p subunits of yeast ATP synthase
differentially affect respiration and fermentation in
Saccharomyces cerevisiae. J Bioenerg Biomembr. 39:127–144.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Granado D, Müller D, Krausel V,
Kruzel-Davila E, Schuberth C, Eschborn M, Wedlich-Söldner R,
Skorecki K, Pavenstädt H, Michgehl U and Weide T: Intracellular
APOL1 risk variants cause cytotoxicity accompanied by energy
depletion. J Am Soc Nephrol. 28:3227–3238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baars TL, Petri S, Peters C and Mayer A:
Role of the V-ATPase in regulation of the vacuolar fission-fusion
equilibrium. Mol Biol Cell. 18:3873–3882. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kruzel-Davila E, Shemer R, Ofir A,
Bavli-Kertselli I, Darlyuk-Saadon I, Oren-Giladi P, Wasser WG,
Magen D, Zaknoun E, Schuldiner M, et al: APOL1-mediated cell injury
involves disruption of conserved trafficking processes. J Am Soc
Nephrol. 28:1117–1130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lan X, Jhaveri A, Cheng K, Wen H, Saleem
MA, Mathieson PW, Mikulak J, Aviram S, Malhotra A, Skorecki K and
Singhal PC: APOL1 risk variants enhance podocyte necrosis through
compromising lysosomal membrane permeability. Am J Physiol Renal
Physiol. 307:F326–F336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vanhamme L, Paturiaux-Hanocq F, Poelvoorde
P, Nolan DP, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van Xong
H, Jacquet A, et al: Apolipoprotein L-I is the trypanosome lytic
factor of human serum. Nature. 422:83–87. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wen H, Kumar V, Lan X, Shoshtari SSM, Eng
JM, Zhou X, Wang F, Wang H, Skorecki K, Xing G, et al: APOL1 risk
variants cause podocytes injury through enhancing endoplasmic
reticulum stress. Biosci Rep. 38:BSR201717132018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Greene AS and Hajduk SL: Trypanosome lytic
factor-1 initiates oxidation stimulated osmotic lysis of
Trypanosoma brucei brucei. J Biol Chem. 291:3063–3075. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng D, Weckerle A, Yu Y, Ma L, Zhu X,
Murea M, Freedman BI, Parks JS and Shelness GS: Biogenesis and
cytotoxicity of APOL1 renal risk variant proteins in hepatocytes
and hepatoma cells. J Lipid Res. 56:1583–1593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Olabisi OA, Zhang JY, VerPlank L, Zahler
N, DiBartolo S III, Heneghan JF, Schlöndorff JS, Suh JH, Yan P,
Alper SL, et al: APOL1 kidney disease risk variants cause
cytotoxicity by depleting cellular potassium and inducing
stress-activated protein kinases. Proc Natl Acad Sci USA.
113:830–837. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Limou S, Dummer PD, Nelson GW, Kopp JB and
Winkler CA: APOL1 toxin, innate immunity, and kidney injury. Kidney
Int. 88:28–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
